Office of Research on Women’s Health (ORWH)
Posted February 1, 2016
I’m often asked to talk about women’s health research at conferences and meetings, and when I do, I show a timeline of the major milestones in women’s health research and in the history of the NIH Office of Research on Women’s Health (ORWH).
This week, I’m adding a milestone to that timeline: NIH grant applications due on or after January 25, 2016, will be evaluated on how they account for sex as a biological variable (SABV) in studies with vertebrate animals and humans. Accounting for SABV in biomedical research will produce robust and relevant new discoveries about basic biology and help to inform sex- and gender-appropriate individualized health care for women and men, boys and girls.
As scientists, we follow wherever the data takes us, but we are also human and may not see beyond our own assumptions. At a recent meeting of the NIH Advisory Committee on Research on Women’s Health, stroke researcher Dr. Louise McCullough described how she repeated her study of ischemic stroke in mice several times — and even switched mouse models — before she finally recognized what was “wrong” with her results: The cells from female and male mice reacted differently because they employ different ischemic cell death pathways. This was a startling discovery: Female and male neurons take distinct avenues to their demise in a model of human stroke. This could mean that certain stroke treatments could work in one sex but not in the other!
Resources for investigators
We are here to help investigators successfully meet the requirements of this new policy. Read our articles “Policy: NIH to balance sex in cell and animal studies” in Nature and “Studying both sexes: a guiding principle for biomedicine” in The FASEB Journal. We also summarize research in the A to Z Guide: Sex and Gender Influences on Health page on our website.
Talk to your program officers early and often. They can help with any questions you have. The Office of Extramural Research also has information online about the policy and grant applications. I’ve summarized some key resources below.
In partnership with virtually all of the 27 Institutes and Centers, ORWH has made supplemental funding available to help researchers explore sex and gender differences within their existing NIH-funded research. The due date for FY2016 administrative supplement applications is March 4. Of special interest are studies that fill a particular gap in our knowledge: the influence of biological sex on cells, including primary cell cultures, in vitro cell cultures, explants, and transformed cells. You can find the highlights from previous rounds of this funding in the recently released Report of the Advisory Committee on Research on Women’s Health.
By asking researchers to take sex into account when designing studies and evaluating and reporting results, NIH will ensure that the influence of sex is examined across the spectrum of biomedical research. Appropriate consideration of the influence of sex in basic, preclinical, and translational research contributes to NIH’s commitment to rigor and reproducibility in research, which will lead to a stronger foundation on which to build clinical research and trials.
We are so very excited about seeing the research that you will be doing and the potential benefits to human health that it will bring. I am confident that this new milestone will pave the way for far-reaching scientific advances in the coming years.
Janine Austin Clayton, M.D.
Associate Director for Research on Women’s Health, NIH
Director, Office of Research on Women’s Health
NIH. (2015, August 13). Principles and guidelines for reporting preclinical research. Retrieved from http://www.nih.gov/science/reproducibility/principles-guidelines.htm
NIH ORWH. (2015, June 8). Online education on sex and gender differences. Retrieved from http://orwh.od.nih.gov/resources/cme.asp
Where to find answers to your questions:
- Email us: NIHReproducibilityEfforts@nih.gov
- Visit our website on Studying Sex to Strengthen Science and explore our Resources page.
Interested in learning more?
- Read my publication in The FASEB Journal.
- See what OER director Mike Lauer has to say in his Open Mike blog post.
- Learn from other investigators who have shared their stories.
- Discover Methods and Techniques for Integrating the Biological Variable Sex into Preclinical Research.
Recent Director’s Articles
Happy 25th Birthday, ORWH!
A quarter-century ago, in September 1990, the NIH Office of Research on Women’s Health was born!
Keeping Scientists in Science: NIH Re-Issues Re-Entry Supplements Funding Opportunity
We all know that critical life events, expected or not, can derail academic careers.
It’s August, and many of us are still in vacation mode.
Considering Sex as a Biological Variable
“Turning discovery into health” is NIH’s mission in just a few words.
About the ORWH Director
Janine Austin Clayton, M.D., was appointed Director for the NIH Office of Research on Women’s Health (ORWH) and Associate Director for NIH Research on Women’s Health by NIH Director Francis S. Collins, M.D., Ph.D., on September 4, 2012.
Dr. Clayton and ORWH in the News
- In a Nature Comment published on May 14, 2014, Dr. Francis Collins and Dr. Janine Clayton outlined NIH steps to address sex differences in preclinical research. This news was covered widely in the media. (May 2014)
- Labs Are Told to Start Including a Neglected Variable: Females , New York Times
- Medical research still short on inclusion of women , USA Today
- Needed: More Females in Animal and Cell Studies , Science magazine
- U.S. health agency to erase sex bias in biomedical studies , The Washington Post, The Chicago Tribune (Reuters)
- Mostly Male, Nature podcast , Nature
- More »